Microbiology and Biotechnology Letters (한국미생물·생명공학회지)

The Korean Society for Microbiology and Biotechnology (한국미생물·생명공학회)
권호 표지
DOI QR코드

DOI QR Code

The Biofilm Eradication Using Gentamicin and Anticoagulants as Catheter-Related Infection Prophylaxis in Hemodialysis Patients : A Systematic Review

  • Natasha, Augustine (Microbiology Department, Faculty of Medicine, Krida Wacana Christian University (UKRIDA)) ;
  • Timotius, Kris Herawan (Microbiology Department, Faculty of Medicine, Krida Wacana Christian University (UKRIDA))
  • Received : 2018.08.31
  • Accepted : 2018.11.12
  • Published : 2019.06.28
Download PDF
⟨ Previous Next ⟩

Abstract

The use of double lumen catheters as a means of hemodialysis access is commonly accompanied with the use of gentamicin as an antibiotic lock. Other antibiotics and anticoagulants are often added to increase the efficacy of gentamicin in order to reduce catheter-related infection and to prevent biofilm formation. This review aimed to evaluate the following: 1) the use of gentamicin in eliminating catheter-related infection and reducing biofilm formation in hemodialysis catheters, 2) the efficacy of additional antibiotics in combination with gentamicin, and 3) the effect of additional anticoagulants to complement the efficacy of gentamicin as the main prophylactic antibiotic lock. We sorted through data from 242 PubMed and ScienceDirect studies, which were then short-listed to 33 studies. Next, they were grouped, extracted, and analyzed qualitatively to fulfil the objectives of this review. Consequently, the use of a gentamicin-lock solution was shown to reduce the incidence of bacteremia; however, it was not strong enough to inhibit the growth of infectious microbes and formation of biofilms. Several bacteria, such as Staphylococcus aureus, Staphylococcus epidermidis, Escherichia coli, and Klebsiella pneumoniae, have been reported as infectious agents. Combination with other antibiotics also provided no effect in reducing bacterial growth and biofilm formation in catheters. Furthermore, the additional anticoagulants (trisodium citrate and EDTA) were reported to be effective in enhancing the efficacy of gentamicin in avoiding catheter-related infection, bacterial growth, and biofilm formation; thus, the use of gentamicin can be rationalized.

Keywords

References

  1. Indonesia Society of Nephrology. 2015. Report of Indonesian renal registry, pp. 5-22. 8th Ed. Pernefri, Jakarta.
  2. Indonesia Society of Nephrology. 2014. Report of Indonesian renal registry, pp. 30. 7th Ed. Pernefri, Jakarta.
  3. Mandolfo S, Borlandelli S, Elli A. 2006. Catheter lock solutions: it's time for a change. J. Vasc. Access 7: 99-102. https://doi.org/10.1177/112972980600700302
  4. Kim SH, Song KI, Chang JW, Kim SB, Sung SA, Jo SK, et al. 2006. Prevention of uncuffed hemodialysis catheter-related bacteremia using an antibiotic lock technique: a prospective, randomized clinical trial. Kidney Int. 69: 161-164. https://doi.org/10.1038/sj.ki.5000012
  5. Jaffer Y, Selby NM, Taal MW, Fluck RJ, McIntyre CW. 2008. A metaanalysis of hemodialysis catheter locking solutions in the prevention of catheter-related infection. Am. J. Kidney Dis. 51: 233-241. https://doi.org/10.1053/j.ajkd.2007.10.038
  6. Labriola L, Crott R, Jadoul M. 2007. Preventing haemodialysis catheter-related bacteraemia with an antimicrobial lock solution: a meta-analysis of prospective randomized trials. Nephrol. Dial. Transplant. 23: 1666-1672. https://doi.org/10.1093/ndt/gfm847
  7. Lee T, Barker J, Allon M. 2005. Tunneled catheters in hemodialysis patients: reasons and subsequent outcomes. Am. J. Kidney Dis. 46: 501-508. https://doi.org/10.1053/j.ajkd.2005.05.024
  8. Goh TL, Wei J, Semple D, Collins J. 2017. The incidence and costs of bacteremia due to lack of gentamicin lock solutions for dialysis catheters. Nephrology 22: 485-489. https://doi.org/10.1111/nep.12960
  9. Manierski C, Besarab A. 2006. Antimicrobial locks: putting the lock on catheter infections. Adv. Chronic Kidney Dis. 13: 245-258. https://doi.org/10.1053/j.ackd.2006.04.003
  10. Nori US, Manoharan A, Yee J, Besarab A. 2006. Comparison of low-dose gentamicin with minocycline as catheter lock solutions in the prevention of catheter-related bacteremia. Am. J. Kidney Dis. 48: 596-605. https://doi.org/10.1053/j.ajkd.2006.06.012
  11. Droste JC, Jeraj HA, MacDonald A, Farrington K. 2003. Stability and in vitro efficacy of antibiotic-heparin lock solutions potentially useful for treatment of central venous catheter-related sepsis. J. Antimicrob. Chemother. 51: 849-855. https://doi.org/10.1093/jac/dkg179
  12. Edmiston Jr CE, Goheen MP, Seabrook GR, Johnson CP, Lewis BD, Brown KR, et al. 2006. Impact of selective antimicrobial agents on staphylococcal adherence to biomedical devices. Am. J. Surg. 192: 344-354. https://doi.org/10.1016/j.amjsurg.2006.04.009
  13. Bookstaver PB, Williamson JC, Tucker BK, Raad II, Sherertz RJ. 2009. Activity of novel antibiotic lock solutions in a model against isolates of catheter-related bloodstream infections. Ann. Pharmacother. 43: 210-219. https://doi.org/10.1345/aph.1L145
  14. Qu Y, Istivan TS, Daley AJ, Rouch DA, Deighton MA. 2009. Comparison of various antimicrobial agents as catheter lock solutions: preference for ethanol in eradication of coagulasenegative staphylococcal biofilms. J. Med. Microbiol. 58: 442-450. https://doi.org/10.1099/jmm.0.006387-0
  15. Parra D, Pena-Monje A, Coronado-Alvarez NM, Hernandez-Quero J, Parra-Ruiz J. 2015. In vitro efficacy of daptomycin and teicoplanin combined with ethanol, clarithromycin or gentamicin as catheter lock solutions. BMC Microbiol. 15: 1-7. https://doi.org/10.1186/s12866-014-0320-5
  16. Zhang J, Wang B, Li R, Ge L, Chen KH, Tian J. 2017. Does antimicrobial lock solution reduce catheter-related infections in hemodialysis patients with central venous catheters? A Bayesian network meta-analysis. Int. Urol. Nephrol. 49: 701-716. https://doi.org/10.1007/s11255-016-1490-x
  17. Fernandez-Hidalgo N, Almirante B, Calleja R, Ruiz I, Planes AM, Rodriguez D, et al. 2006. Antibiotic-lock therapy for long-term intravascular catheter-related bacteraemia: results of an open, non-comparative study. J. Antimicrob. Chemother. 57: 1172-1180. https://doi.org/10.1093/jac/dkl103
  18. Hadaway L. 2006. Heparin Locking for Central Venous Catheters. JAVA. 11: 224-231. https://doi.org/10.2309/java.11-4-17
  19. Percival SL, Kite P, Eastwood K, Murga R, Carr J, Arduino MJ, et al. 2005. Tetrasodium EDTA as a novel central venous catheter lock solution against biofilm. Infect. Control Hosp. Epidemiol. 26: 515-519. https://doi.org/10.1086/502577
  20. Raad II, Fang X, Keutgen XM, Jiang Y, Sherertz R, Hachem R. 2008. The role of chelators in preventing biofilm formation and catheter-related bloodstream infections. Curr. Opin Infect. Dis. 21: 385-392. https://doi.org/10.1097/QCO.0b013e32830634d8
  21. Takla TA, Zelenitsky SA, Vercaigne LM. 2008. Effectiveness of a 30% ethanol/4% trisodium citrate locking solution in preventing biofilm formation by organisms causing haemodialysis catheterrelated infections. J. Antimicrob. Chemother. 62: 1024-1026. https://doi.org/10.1093/jac/dkn291
  22. Bosma JW, Siegert CE, Peerbooms PG, Weijmer MC. 2009. Reduction of biofilm formation with trisodium citrate in haemodialysis catheters: a randomized controlled trial. Nephrol. Dial. Transplant. 25: 1213-1217. https://doi.org/10.1093/ndt/gfp651
  23. Allon M. 2008. Prophylaxis against dialysis catheter-related bacteremia: A glimmer of hope. Am. J. Kidney Dis. 51: 165-168. https://doi.org/10.1053/j.ajkd.2007.12.003
  24. Branas P, Morales E, Rios F, Sanz F, Gutierrez E, Quintanilla N, et al. 2014. Usefulness of endoluminal catheter colonization surveillance cultures to reduce catheter-related bloodstream infections in hemodialysis. Am. J. Infect. Control. 42: 1182-1187. https://doi.org/10.1016/j.ajic.2014.07.022
  25. Fortun J, Grill F, Martin-Davila P, Blazquez J, Tato M, Sanchez-Corral J, et al. 2006. Treatment of long-term intravascular catheterrelated bacteraemia with antibiotic-lock therapy. J. Antimicrob. Chemother. 58: 816-821. https://doi.org/10.1093/jac/dkl318
  26. Curtin J, Cormican M, Fleming G, Keelehan J, Colleran E. 2003. Linezolid compared with eperezolid, vancomycin, and gentamicin in an in vitro model of antimicrobial lock therapy for Staphylococcus epidermidis central venous catheter-related biofilm infections. Antimicrob. Agents Chemother. 47: 3145-3148. https://doi.org/10.1128/AAC.47.10.3145-3148.2003
  27. Andris DA, Krzywda EA, Edmiston CE, Krepel CJ, Gohr CM. 1998. Elimination of intraluminal colonization by antibiotic lock in silicone vascular catheters. Nutrition 14: 427-432. https://doi.org/10.1016/S0899-9007(98)00013-6
  28. Fernandez-Hidalgo N, Gavalda J, Almirante B, Martín M-T, Lopez Onrubia P, Gomis X, Pahissa A. 2010. Evaluation of linezolid, vancomycin, gentamicin and ciprofloxacin in a rabbit model of antibiotic-lock technique for Staphylococcus aureus catheter-related infection. J. Antimicrob. Chemother. 65: 525-530. https://doi.org/10.1093/jac/dkp499
  29. Chaudhury A, Rangineni J, Venkatramana B. 2012. Catheter lock technique: in vitro efficacy of ethanol for eradication of methicillin-resistant staphylococcal biofilm compared with other agents. FEMS Immunol. Med. Microbiol. 65: 305-308. https://doi.org/10.1111/j.1574-695X.2012.00950.x
  30. Chauhan A, Lebeaux D, Ghigo J-M, Beloin C. 2012. Full and broad-spectrum in vivo eradication of catheter-associated biofilms using gentamicin-EDTA antibiotic lock therapy. Antimicrob. Agents Chemother. 56: 6310-6318. https://doi.org/10.1128/AAC.01606-12
  31. Lebeaux D, Leflon-Guibout V, Ghigo J-M, Beloin C. 2015. In vitro activity of gentamicin, vancomycin or amikacin combined with EDTA or l-arginine as lock therapy against a wide spectrum of biofilm-forming clinical strains isolated from catheter-related infections. J. Antimicrob. Chemother. 70: 1704-1712. https://doi.org/10.1093/jac/dkv044
  32. Lee J-Y, Ko KS, Peck KR, Oh WS, Song J-H. 2006. In vitro evaluation of the antibiotic lock technique (ALT) for the treatment of catheter-related infections caused by staphylococci. J. Antimicrob. Chemother. 57: 1110-1115. https://doi.org/10.1093/jac/dkl098
  33. Moore CL, Besarab A, Ajluni M, Soi V, Peterson EL, Johnson LE, et al. 2014. Comparative effectiveness of two catheter locking solutions to reduce catheter-related bloodstream infection in hemodialysis patients. Clin. J. Am. Soc. Nephrol. 9: 1232-1239. https://doi.org/10.2215/CJN.11291113
  34. Moran J, Sun S, Khababa I, Pedan A, Doss S, Schiller B. 2012. A randomized trial comparing gentamicin/citrate and heparin locks for central venous catheters in maintenance hemodialysis patients. Am. J. Kidney Dis. 59: 102-107. https://doi.org/10.1053/j.ajkd.2011.08.031
  35. Pervez A, Ahmed M, Ram S, Torres C, Work J, Zaman F, Abreo K. 2002. Antibiotic lock technique for prevention of cuffed tunnel catheter associated bacteremia. J. Vasc. Access. 3: 108-113. https://doi.org/10.1177/112972980200300305
  36. Abbas SA, Haloob IA, Taylor SL, Curry EM, King BB, Van der Merwe WM, et al. 2009. Effect of antimicrobial locks for tunneled hemodialysis catheters on bloodstream infection and bacterial resistance: a quality improvement report. Am. J. Kidney Dis. 53: 492-502. https://doi.org/10.1053/j.ajkd.2008.09.019
  37. McIntyre CW, Hulme LJ, Taal M, Fluck RJ. 2004. Locking of tunneled hemodialysis catheters with gentamicin and heparin. Kidney Int. 66: 801-805. https://doi.org/10.1111/j.1523-1755.2004.00806.x
  38. Dogra GK, Herson H, Hutchison B, Irish AB, Heath CH, Golledge C, et al. 2002. Prevention of tunneled hemodialysis catheter-related infections using catheter-restricted filling with gentamicin and citrate: a randomized controlled study. J. Am. Soc. Nephrol. 13: 2133-2139. https://doi.org/10.1097/01.ASN.0000022890.29656.22
  39. Zhang P, Yuan J, Tan H, Lv R, Chen J. 2009. Successful prevention of cuffed hemodialysis catheter-related infection using an antibiotic lock technique by strictly catheter-restricted antibiotic lock solution method. Blood Purif. 27: 206-211. https://doi.org/10.1159/000197560
  40. Silva J, e Costa T, Baptista A, Ramos A, Ponce P. 2008. Catheterrelated bacteremia in hemodialysis: which preventive measures to take? Nephron. Clin. Pract. 110: c251-c257. https://doi.org/10.1159/000167873
  41. Filiopoulos V, Hadjiyannakos D, Koutis I, Trompouki S, Micha T, Lazarou D, Vlassopoulos D. 2011. Approaches to prolong the use of uncuffed hemodialysis catheters: results of a randomized trial. Am. J. Nephrol. 33: 260-268. https://doi.org/10.1159/000324685
  42. Silva T, Mendes M, Abrao JMG, Caramori J, Ponce D. 2013. Successful prevention of tunneled central catheter infection by antibiotic lock therapy using cefazolin and gentamicin. Int. Urol. Nephrol. 45: 1405-1413. https://doi.org/10.1007/s11255-012-0339-1
  43. Chow K, Poon Y, Lam M, Poon K, Szeto C, Li P. 2010. Antibiotic lock solutions for the prevention of catheter-related bacteraemia in haemodialysis patients. Hong Kong Med. J. 16: 269-274.
  44. Venditto M, du Montcel ST, Robert J, Trystam D, Dighiero J, Hue D, et al. 2010. Effect of catheter-lock solutions on catheter-related infection and inflammatory syndrome in hemodialysis patients: heparin versus citrate 46% versus heparin/gentamicin. Blood Purif. 29: 268-273. https://doi.org/10.1159/000274461
  45. Feely T, Copley A, Bleyer AJ. 2007. Catheter lock solutions to prevent bloodstream infections in high-risk hemodialysis patients. Am. J. Nephrol. 27: 24-29. https://doi.org/10.1159/000098541
  46. Araoka H, Kimura M, Yoneyama A. 2011. A surveillance of highlevel gentamicin-resistant enterococcal bacteremia. J. Infect. Chemother. 17: 433-434. https://doi.org/10.1007/s10156-010-0175-0
  47. Dadfarma N, Fooladi AAI, Oskoui M, Hosseini HM. 2013. High level of gentamicin resistance (HLGR) among Enterococcus strains isolated from clinical specimens. J. Infect. Public Health 6: 202-208. https://doi.org/10.1016/j.jiph.2013.01.001
  48. Uechi K, Tada T, Shimada K, Nakasone I, Sonozaki T, Kirikae T, Fujita J. 2018. Emergence of ArmA, a 16S rRNA methylase in highly aminoglycoside-resistant clinical isolates of Klebsiella pneumoniae and Klebsiella oxytoca in Okinawa, Japan. J. Infect. Chemother. 24: 68-70. https://doi.org/10.1016/j.jiac.2017.09.006
  49. Szymanek-Majchrzak K, Mlynarczyk A, Kawecki D, Pacholczyk M, Durlik M, Deborska-Materkowska D, et al. 2018. Resistance to aminoglycosides of methicillin-resistant strains of Staphylococcus aureus, originating in the surgical and transplantation wards of the Warsaw clinical center-a retrospective analysis. Transplant. Proc. 50: 2170-2175. https://doi.org/10.1016/j.transproceed.2018.02.158
  50. Landry DL, Braden GL, Gobeille SL, Haessler SD, Vaidya CK, Sweet SJ. 2010. Emergence of gentamicin-resistant bacteremia in hemodialysis patients receiving gentamicin lock catheter prophylaxis. Clin. J. Am. Soc. Nephrol. 5: 1799-1804. https://doi.org/10.2215/CJN.01270210
  51. Al-Hwiesh AK. 2008. Tunneled catheter-antibiotic lock therapy for prevention of dialysis catheter-related infections: a single center experience. Saudi J. Kidney Dis. Transpl. 19: 593-602.
  52. Al-Hwiesh AK, Abdul-Rahman IS. 2007. Successful prevention of tunneled, central catheter infection by antibiotic lock therapy using vancomycin and gentamycin. Saudi J. Kidney Dis. Transpl. 18: 239-247.
  53. Dixon JJ, Steele M, Makanjuola AD. 2012. Anti-microbial locks increase the prevalence of Staphylococcus aureus and antibioticresistant Enterobacter : observational retrospective cohort study. Nephrol. Dial. Transplant. 27: 3575-3581. https://doi.org/10.1093/ndt/gfs081
  54. Vercaigne LM, Zelenitsky SA, Findlay I, Bernstein K, Penner SB. 2002. An in vitro evaluation of the antibiotic/heparin lock to sterilize central venous haemodialysis catheters. J. Antimicrob. Chemother. 49: 693-696. https://doi.org/10.1093/jac/49.4.693
  55. Shanks RM, Sargent JL, Martinez RM, Graber ML, O'toole GA. 2006. Catheter lock solutions influence staphylococcal biofilm formation on abiotic surfaces. Nephrol. Dial. Transplant. 21: 2247-2255. https://doi.org/10.1093/ndt/gfl170
  56. Weijmer MC, van den Dorpel MA, Van de Ven PJ, ter Wee PM, van Geelen JA, Groeneveld JO, et al. 2005. Randomized, clinical trial comparison of trisodium citrate 30% and heparin as catheterlocking solution in hemodialysis patients. J. Am. Soc. Nephrol. 16: 2769-2777. https://doi.org/10.1681/ASN.2004100870